U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula 2C3H5O3.Fe.3H2O
Molecular Weight 288.031
Optical Activity ( + / - )
Defined Stereocenters 0 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FERROUS LACTATE TRIHYDRATE

SMILES

O.O.O.[Fe++].CC(O)C([O-])=O.CC(O)C([O-])=O

InChI

InChIKey=VPKDTEBBNJPGBH-UHFFFAOYSA-L
InChI=1S/2C3H6O3.Fe.3H2O/c2*1-2(4)3(5)6;;;;/h2*2,4H,1H3,(H,5,6);;3*1H2/q;;+2;;;/p-2

HIDE SMILES / InChI

Molecular Formula Fe
Molecular Weight 55.845
Charge 2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C3H5O3
Molecular Weight 89.07
Charge -1
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Molecular Formula H2O
Molecular Weight 18.0153
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Iron(II) gluconate (also known as a ferrous gluconate) is used in the treatment of hypochromic anemia. The real problem of iron therapy is not the theoretical utilization of iron, or the reticulocyte response, or even the daily increase of hemoglobin. These are important only as they indicate the return of the patients' blood to normal in a reasonably short time without undue inconvenience. Most patients suffering from hypochromic anemia respond well to most forms of iron when administered in adequate dosage. For the patients who cannot tolerate the usual iron compounds, it is important to have a medication which is effective and which causes minimum disturbance. Ferrous gluconate is such a medicament.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
Unknown

Approved Use

Unknown
Palliative
Unknown

Approved Use

Unknown
Primary
Ferro Sanol Duodenal

Approved Use

Ferro Sanol is an iron substitute in case of latent or manifest iron deficiency with and without development of anaemia.
PubMed

PubMed

TitleDatePubMed
FERROUS IODIDE AND LINOLEIC ACID IN VITAMIN A DEFICIENCY. A REPLY TO CERTAIN CRITICISMS.
1932 Nov 11
THE ADMINISTRATION OF FERROUS IODIDE AND LINOLEIC ACID TO RATS DEPRIVED OF VITAMIN A.
1932 Sep 30
[FERROUS ASPARTATE IN THERAPY].
1964 Jan 1
Reversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and 5-bromotetrandrine in xenograft nude-mice.
2009
The effect of iron treatment on adhesion molecules in patients with iron deficiency anemia.
2010 Dec
Tolerability of different oral iron supplements: a systematic review.
2013 Apr
Reactivity enhancement of iron sulfide nanoparticles stabilized by sodium alginate: Taking Cr (VI) removal as an example.
2017 Jul 5
Continuous sulfidogenic wastewater treatment with iron sulfide sludge oxidation and recycle.
2017 May 1
Patents

Sample Use Guides

Unknown
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:46:58 UTC 2023
Edited
by admin
on Fri Dec 15 16:46:58 UTC 2023
Record UNII
IEP40B1R5X
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FERROUS LACTATE TRIHYDRATE
MI  
Common Name English
IRON(II) LACTATE TRIHYDRATE
Systematic Name English
LACTIC ACID, IRON(2+) SALT (2:1), TRIHYDRATE
Common Name English
FERROUS LACTATE TRIHYDRATE, (±)-
Common Name English
(±)-FERROUS LACTATE TRIHYDRATE
Common Name English
FERRUM LACTICUM [HPUS]
Common Name English
PROPANOIC ACID, 2-HYDROXY-, IRON COMPLEX
Common Name English
FERROUS LACTATE TRIHYDRATE [MI]
Common Name English
FERRUM LACTICUM
HPUS  
Common Name English
IRON, BIS(LACTATO)-, TRIHYDRATE
Common Name English
Code System Code Type Description
FDA UNII
IEP40B1R5X
Created by admin on Fri Dec 15 16:46:59 UTC 2023 , Edited by admin on Fri Dec 15 16:46:59 UTC 2023
PRIMARY
EPA CompTox
DTXSID30975878
Created by admin on Fri Dec 15 16:46:59 UTC 2023 , Edited by admin on Fri Dec 15 16:46:59 UTC 2023
PRIMARY
CAS
6047-24-1
Created by admin on Fri Dec 15 16:46:59 UTC 2023 , Edited by admin on Fri Dec 15 16:46:59 UTC 2023
PRIMARY
PUBCHEM
201470
Created by admin on Fri Dec 15 16:46:59 UTC 2023 , Edited by admin on Fri Dec 15 16:46:59 UTC 2023
PRIMARY
MERCK INDEX
m5347
Created by admin on Fri Dec 15 16:46:59 UTC 2023 , Edited by admin on Fri Dec 15 16:46:59 UTC 2023
PRIMARY Merck Index
Related Record Type Details
ANHYDROUS->SOLVATE
PARENT -> SALT/SOLVATE